Our Team
The people leading CureLogic
Gwen Swan is a philosopher, mathematician, and strategist exploring AI, human rights, and decentralised governance.
As the founder and CEO of CureLogic Ltd., IPPON FinTech, and FFA Ventures, Gwen has led pioneering efforts in biotechnology, IP asset securitisation, and startup acceleration across global markets. Her thought leadership spans technological innovation, legal theory, and ethical design — driven by a lifelong commitment to equity, intelligence, and human dignity.
Professor Krams holds a Chair in Molecular Bioengineering at Imperial College, London.
Professor Krams was trained at the Free University Amsterdam, where he did his PhD. After two years in the USA, he joined the Bioengineering team of the Thorax centre in Rotterdam, and was a recipient of an Established Investigator award (2003–2008). He joined Imperial College London in 2007 as a full professor in Bioengineering, and in 2018 joined QMUL. He is an associate editor of 12 journals and has written over 500 papers.
Meet the people behind the breakthroughs
CureLogic is driven by a leadership team with a proven track record in medical science, AI research, and organisational excellence — ensuring every initiative is executed with precision, impact, and integrity.
Want to work with the minds shaping the future of healthcare?
Join forces with our experts.